CA2308513A1 - Method and composition for delivering zinc to the nasal membrane - Google Patents
Method and composition for delivering zinc to the nasal membrane Download PDFInfo
- Publication number
- CA2308513A1 CA2308513A1 CA002308513A CA2308513A CA2308513A1 CA 2308513 A1 CA2308513 A1 CA 2308513A1 CA 002308513 A CA002308513 A CA 002308513A CA 2308513 A CA2308513 A CA 2308513A CA 2308513 A1 CA2308513 A1 CA 2308513A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- nasal membrane
- delivering zinc
- delivering
- zinc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A viscous gel for delivering minor effective amounts of active substances through the nasal membrane into the body.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/145,042 US6080783A (en) | 1998-09-01 | 1998-09-01 | Method and composition for delivering zinc to the nasal membrane |
US09/145,042 | 1998-09-01 | ||
PCT/US1999/020185 WO2000012081A1 (en) | 1998-09-01 | 1999-09-01 | Method and composition for delivering zinc to the nasal membrane |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2308513A1 true CA2308513A1 (en) | 2000-03-09 |
CA2308513C CA2308513C (en) | 2005-01-04 |
Family
ID=22511336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002308513A Expired - Fee Related CA2308513C (en) | 1998-09-01 | 1999-09-01 | Method and composition for delivering zinc to the nasal membrane |
Country Status (9)
Country | Link |
---|---|
US (8) | US6080783A (en) |
EP (1) | EP1039896A4 (en) |
JP (2) | JP2002523453A (en) |
KR (1) | KR100439323B1 (en) |
CN (1) | CN1293869C (en) |
AU (1) | AU774410B2 (en) |
BR (1) | BR9906758A (en) |
CA (1) | CA2308513C (en) |
WO (1) | WO2000012081A1 (en) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7022683B1 (en) * | 1998-05-13 | 2006-04-04 | Carrington Laboratories, Inc. | Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation |
US6080783A (en) * | 1998-09-01 | 2000-06-27 | Gum Tech International, Inc. | Method and composition for delivering zinc to the nasal membrane |
US20050232868A1 (en) * | 1999-10-19 | 2005-10-20 | The Procter & Gamble Company | Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions |
US20040033260A1 (en) * | 1999-10-19 | 2004-02-19 | The Procter & Gamble Company | Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc |
US20040234457A1 (en) * | 1999-10-19 | 2004-11-25 | The Procter & Gamble Company | Methods of preventing and treating SARS using low pH respiratory tract compositions |
AU2002239801A1 (en) * | 2000-10-27 | 2002-06-03 | Pearl Street Financial Group Ltd. | Debt financing for companies |
US6777000B2 (en) * | 2001-02-28 | 2004-08-17 | Carrington Laboratories, Inc. | In-situ gel formation of pectin |
US7494669B2 (en) * | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
US20030215491A1 (en) * | 2001-04-30 | 2003-11-20 | Hensley Charles B. | Method and composition for rapid delivery of bioactive compounds to the systemic circulation via the nasal membrane |
MXPA04003359A (en) * | 2001-10-12 | 2004-11-29 | Cns Corporated | Hydrating nasal gel and applicator. |
US8679462B2 (en) * | 2002-04-11 | 2014-03-25 | Saeed Rezakhany | Methods of preventing respiratory infections |
US20090035260A1 (en) * | 2002-07-29 | 2009-02-05 | Therapicon Srl | Enhanced nasal composition of active peptide |
WO2004011017A1 (en) * | 2002-07-31 | 2004-02-05 | Himalayan International Institute Of Yoga Science And Philosophy | Nasal irrigation solutions and methods of using same |
AU2003272517A1 (en) * | 2002-09-13 | 2004-04-30 | Zicam, Llc. | Compositions to reduce congestion and methods for application thereof to the nasal membrane |
WO2004024225A1 (en) | 2002-09-16 | 2004-03-25 | Zicam, Llc. | System and method for delivering a composition to the nasal membrane |
DE10358372A1 (en) * | 2003-04-03 | 2004-10-14 | Basf Ag | Trimethylolpropane esters are useful for the production of cross-linked hydrogels, useful for the production of hygiene articles, packaging materials and non-wovens |
US20070092583A1 (en) * | 2003-04-30 | 2007-04-26 | Tim Clarot | Cold remedy composition comprising zinc salts |
US8216171B2 (en) * | 2003-07-15 | 2012-07-10 | Deka Products Limited Partnership | Individual dose packaging |
US20050043253A1 (en) * | 2003-08-19 | 2005-02-24 | Cook Bradley R. | Use of wound healing compositions for prevention of infections and allergies |
US7968122B2 (en) * | 2003-12-10 | 2011-06-28 | Adventrx Pharmaceuticals, Inc. | Anti-viral pharmaceutical compositions |
ITMI20040235A1 (en) * | 2004-02-13 | 2004-05-13 | Therapicon Srl | PHARMACEUTICAL PREPARATION FOR THE ORAL CABLE |
EP1819222A2 (en) * | 2004-12-09 | 2007-08-22 | The Dial Corporation | Compositions having a high antiviral and antibacterial efficacy |
US20090012174A1 (en) * | 2004-12-09 | 2009-01-08 | The Dial Corporation | Compositions Having a High Antiviral and Antibacterial Efficacy |
WO2006062857A2 (en) * | 2004-12-09 | 2006-06-15 | The Dial Corporation | Compositions having a high antiviral and antibacterial efficacy |
US20080095814A1 (en) * | 2004-12-09 | 2008-04-24 | The Dial Corporation | Compositions Having a High Antiviral and Antibacterial Efficacy |
MX2007006862A (en) * | 2004-12-09 | 2008-02-15 | Dial Corp | Compositions having a high antiviral and antibacterial efficacy. |
US20070135377A1 (en) * | 2004-12-10 | 2007-06-14 | Roman Stephen B | Thixotropic anti-viral formulation |
US20090076132A1 (en) * | 2005-03-11 | 2009-03-19 | Gary Pekoe | Antiviral compositions and methods of treatment |
US20070009443A1 (en) * | 2005-07-05 | 2007-01-11 | Hensley Charles B | Method for inhibiting occupation by rhinovirus of cell in the nasal membrane |
US20070111964A1 (en) * | 2005-08-17 | 2007-05-17 | Fleming And Company, Pharmaceuticals | Vitamin B12 nasal spray and method of use |
US20070110676A1 (en) * | 2005-11-17 | 2007-05-17 | The Procter & Gamble Company | Compositions useful for prevention and treatment of common cold and influenza-like symptoms |
EP2040543A2 (en) * | 2006-05-24 | 2009-04-01 | The Dial Corporation | Composition and method for controlling the transmission of noroviruses |
MX2008015088A (en) * | 2006-05-26 | 2009-03-05 | Dial Corp | Method of inhibiting the transmission of viruses. |
WO2007142919A2 (en) | 2006-05-30 | 2007-12-13 | The Dial Corporation | Compositions having a high antiviral effeicacy |
EP2034831A2 (en) * | 2006-05-31 | 2009-03-18 | The Dial Corporation | Alcohol-containing antimicrobial compositions having improved efficacy |
RU2431961C2 (en) | 2006-06-02 | 2011-10-27 | Дзе Дайл Корпорейшн | Method of inhibiting transfer of influenza virus |
EP2046120A2 (en) * | 2006-06-05 | 2009-04-15 | The Dial Corporation | Methods and articles having a high antiviral and antibacterial efficacy |
WO2008037470A1 (en) * | 2006-09-27 | 2008-04-03 | Niconovum Ab | Directional use |
DE102007045368A1 (en) * | 2007-09-22 | 2009-04-02 | Zf Friedrichshafen Ag | Method and device for lubricating the axial starts of idler gears arranged on a shaft |
WO2009099405A2 (en) * | 2008-01-30 | 2009-08-13 | Dalos, Llc | Antibacterial compositions and methods of treatment |
US8241236B2 (en) * | 2008-03-21 | 2012-08-14 | Y B Innovations, Llc | Apparatus for cleaning a nasal cavity |
GB2460815A (en) * | 2008-04-04 | 2009-12-16 | Kays Medical | A sterilisable gel formulation comprising calcium gluconate |
US8173183B2 (en) | 2008-07-02 | 2012-05-08 | Carmell Hergert | Mucosal membrane healant and moisturizer |
US20100021563A1 (en) * | 2008-07-24 | 2010-01-28 | Paul Levesque | Compositions comprising coconut oil and methods of use thereof |
BR112012012945A2 (en) | 2009-11-25 | 2020-12-29 | Arisgen Sa | MUCOSAL RELEASE COMPOSITION, ITS PRODUCTION METHOD, PRE-FORMED PEPTIDE COMPLEX, KIT AND USE OF AN ACTIVE PEPTIDE AGENT |
WO2012119102A2 (en) * | 2011-03-03 | 2012-09-07 | Cearna Inc. | Homeopathic therapeutic method and compositions |
US10022335B2 (en) | 2011-03-03 | 2018-07-17 | Nancy Josephine Polich | Homeopathic therapeutic method and compositions |
US9034401B1 (en) | 2014-01-23 | 2015-05-19 | Matrixx Initiatives, Inc. | Pharmaceutical compositions comprising plant extracts and methods for reducing duration of a common cold using same |
CA2992352C (en) * | 2015-07-14 | 2023-06-27 | Marinomed Biotech Ag | Stuffy nose deblocking composition having antiviral activity |
KR20180120204A (en) | 2016-02-25 | 2018-11-05 | 어플라이드 바이올로지컬 래버러토리즈 인코포레이티드 | Compositions and methods for protecting airborne pathogens and stimulants |
KR101825041B1 (en) * | 2016-04-07 | 2018-02-02 | 주식회사 바이오솔루션 | Skin External composition for treating a wound comprising substance P |
JOP20190148A1 (en) * | 2016-12-21 | 2019-06-18 | Bayer Pharma AG | Pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors, and the use of same in breathing disorder therapy |
KR20200139170A (en) * | 2018-04-06 | 2020-12-11 | 필립모리스 프로덕츠 에스.에이. | Nicotine gel |
FR3113237B1 (en) * | 2020-08-04 | 2023-06-09 | Biopass | PRODUCT FOR THE TREATMENT OF VIRAL DISEASES BY NASAL WAY |
CA3188053A1 (en) * | 2020-08-04 | 2022-02-10 | Stephanie Audran | Hydrogel comprising glycerol and a carbomer for treating the respiratory symptoms of covid-19 disease via the nasal route |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3965908A (en) * | 1975-01-02 | 1976-06-29 | Posthuma Albert E | Synthetic physiological mucus |
US5002970A (en) | 1981-07-31 | 1991-03-26 | Eby Iii George A | Flavor masked ionizable zinc compositions for oral absorption |
US4503070A (en) | 1981-07-31 | 1985-03-05 | Eby Iii George A | Method for reducing the duration of the common cold |
US5095035A (en) | 1981-07-31 | 1992-03-10 | Eby Iii George A | Flavor stable zinc acetate compositions for oral absorption |
US5409905A (en) | 1981-01-05 | 1995-04-25 | Eby, Iii; George A. | Cure for commond cold |
US5286748A (en) | 1981-01-05 | 1994-02-15 | Eby Iii George A | General method of shortening the duration of common colds by application of medicaments to tissues of oral cavity |
US4956385A (en) | 1981-07-31 | 1990-09-11 | Eby Iii George A | Method for reducing the duration of the common cold |
USRE33465E (en) | 1981-07-31 | 1990-11-27 | Method for reducing the duration of the common cold | |
GB2133691B (en) * | 1983-01-21 | 1986-05-21 | Leo Ab | Smoking substitutes for nasal administration |
US4686528A (en) | 1984-01-31 | 1987-08-11 | Motorola, Inc. | Method of encoding and decoding data signals |
US4758439A (en) | 1984-06-11 | 1988-07-19 | Godfrey Science & Design, Inc. | Flavor of zinc supplements for oral use |
DE3431727A1 (en) * | 1984-08-29 | 1986-03-13 | Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen | Nasal spray for coryza and influenza with a content of zinc gluconate |
US4724231A (en) * | 1985-04-16 | 1988-02-09 | Nastech Pharmaceutical, Inc. | Nasel compositions containing vitamin B12 |
JPS63101318A (en) * | 1986-10-16 | 1988-05-06 | Toko Yakuhin Kogyo Kk | Collunarium |
US4778810A (en) * | 1987-01-08 | 1988-10-18 | Nastech Pharmaceutical Co., Inc. | Nasal delivery of caffeine |
EP0296227A1 (en) * | 1987-01-08 | 1988-12-28 | Nastech Pharmaceutical Company, Inc. | Nasal delivery of amino acids |
JPS63174924A (en) * | 1987-01-14 | 1988-07-19 | Toko Yakuhin Kogyo Kk | Ointment base and ointment |
ATE84968T1 (en) * | 1987-11-13 | 1993-02-15 | Asta Medica Ag | MEDICATIONS CONTAINING AZELASTINE FOR NOSE AND/OR EYE USE. |
US4885287A (en) | 1988-08-09 | 1989-12-05 | University Of Kentucky Research Foundation | Novel method of administering aspirin and dosage forms containing same |
GB8902300D0 (en) | 1989-02-02 | 1989-03-22 | Bryce Smith Derek | Antirhinoviral preparations |
JPH0678245B2 (en) * | 1989-07-04 | 1994-10-05 | 東興薬品工業株式会社 | Influenza vaccine gel formulation for nasal spray administration |
US5158761A (en) * | 1989-04-05 | 1992-10-27 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
US5208031A (en) * | 1989-06-06 | 1993-05-04 | Kelly Patrick D | Sexual lubricants containing zinc as an anti-viral agent |
US5785054A (en) * | 1989-06-06 | 1998-07-28 | Kelly; Patrick D. | Genital lubricant with zinc salt, labelled as anti-viral agent |
GB8916625D0 (en) * | 1989-07-20 | 1989-09-06 | Bryce Smith Derek | Respiratory tract spray preparations |
IL101056A (en) * | 1992-02-24 | 1997-03-18 | Res & Dev Co Ltd | Composition for nasal treatment |
GB9218834D0 (en) * | 1992-09-05 | 1992-10-21 | Procter & Gamble | Nasal spray products |
US5760085A (en) * | 1993-04-30 | 1998-06-02 | The Procter & Gamble Company | Topical aromatic releasing compositions |
JPH07316038A (en) * | 1994-05-23 | 1995-12-05 | Ikeda Mohandou:Kk | Medicine composition for mucosal administration |
US5747058A (en) * | 1995-06-07 | 1998-05-05 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
US5733535A (en) * | 1995-10-25 | 1998-03-31 | The Procter & Gamble Co. | Topical compositions containing N-acetylcysteine and odor masking materials |
US6344210B2 (en) * | 1996-05-10 | 2002-02-05 | Charles A. Fust | Composition for freshening nostrils and sinus cavities |
US5906811A (en) * | 1997-06-27 | 1999-05-25 | Thione International, Inc. | Intra-oral antioxidant preparations |
US6080783A (en) * | 1998-09-01 | 2000-06-27 | Gum Tech International, Inc. | Method and composition for delivering zinc to the nasal membrane |
US6929800B2 (en) * | 2001-08-06 | 2005-08-16 | Abdul Rasoul Salman | Nasal passage cleaning composition |
WO2004024225A1 (en) * | 2002-09-16 | 2004-03-25 | Zicam, Llc. | System and method for delivering a composition to the nasal membrane |
CN101198687A (en) * | 2005-06-18 | 2008-06-11 | 宝洁公司 | Cleansing bar compositions comprising a high level of water |
-
1998
- 1998-09-01 US US09/145,042 patent/US6080783A/en not_active Expired - Lifetime
-
1999
- 1999-09-01 BR BR9906758-7A patent/BR9906758A/en not_active Application Discontinuation
- 1999-09-01 US US09/388,816 patent/US6673835B1/en not_active Expired - Fee Related
- 1999-09-01 CN CNB998019860A patent/CN1293869C/en not_active Expired - Fee Related
- 1999-09-01 CA CA002308513A patent/CA2308513C/en not_active Expired - Fee Related
- 1999-09-01 WO PCT/US1999/020185 patent/WO2000012081A1/en active IP Right Grant
- 1999-09-01 KR KR10-2000-7004741A patent/KR100439323B1/en not_active IP Right Cessation
- 1999-09-01 AU AU59075/99A patent/AU774410B2/en not_active Ceased
- 1999-09-01 JP JP2000567198A patent/JP2002523453A/en active Pending
- 1999-09-01 EP EP99946733A patent/EP1039896A4/en not_active Withdrawn
-
2000
- 2000-06-26 US US09/603,864 patent/US6365624B1/en not_active Expired - Fee Related
-
2001
- 2001-09-12 US US09/956,744 patent/US20020032231A1/en not_active Abandoned
-
2003
- 2003-11-25 US US10/722,811 patent/US20040109895A1/en not_active Abandoned
-
2005
- 2005-01-03 US US11/028,991 patent/US7348360B2/en not_active Expired - Fee Related
-
2007
- 2007-07-23 US US11/781,396 patent/US20070265337A1/en not_active Abandoned
- 2007-08-20 JP JP2007213993A patent/JP2008013572A/en active Pending
-
2010
- 2010-10-14 US US12/904,749 patent/US7989003B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2008013572A (en) | 2008-01-24 |
BR9906758A (en) | 2002-01-15 |
US20040109895A1 (en) | 2004-06-10 |
US6080783A (en) | 2000-06-27 |
EP1039896A4 (en) | 2007-08-15 |
US7989003B2 (en) | 2011-08-02 |
CN1293869C (en) | 2007-01-10 |
CN1287486A (en) | 2001-03-14 |
US7348360B2 (en) | 2008-03-25 |
AU5907599A (en) | 2000-03-21 |
KR100439323B1 (en) | 2004-07-07 |
KR20010031680A (en) | 2001-04-16 |
CA2308513C (en) | 2005-01-04 |
US6673835B1 (en) | 2004-01-06 |
WO2000012081A1 (en) | 2000-03-09 |
US20050118243A1 (en) | 2005-06-02 |
US6365624B1 (en) | 2002-04-02 |
JP2002523453A (en) | 2002-07-30 |
AU774410B2 (en) | 2004-06-24 |
US20070265337A1 (en) | 2007-11-15 |
US20110077296A1 (en) | 2011-03-31 |
EP1039896A1 (en) | 2000-10-04 |
US20020032231A1 (en) | 2002-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2308513A1 (en) | Method and composition for delivering zinc to the nasal membrane | |
AU2977695A (en) | Compositions for applying active substances to or through the skin | |
CA2204626A1 (en) | Hydrocarbyl containing coatings, compositions and methods of use | |
AU5743996A (en) | Compositions and methods for nucleic acid delivery to the lu ng | |
IL122783A0 (en) | Cell adhesion inhibitors and pharmaceutical compositions containing the same | |
HUP9601566A3 (en) | Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component | |
AU1663195A (en) | Liquid pharmaceutical compositions comprising thyroid hormones | |
EP0684044A3 (en) | Composition consisting of a dendrimer and an active substance. | |
AU571372B2 (en) | Gel based delivery of active substances | |
CA2307607A1 (en) | Powdery nasal compositions | |
CA2154424A1 (en) | 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect | |
AU9021298A (en) | Agmatine as a treatment for neuropathic pain | |
WO1998018500A8 (en) | Improvements in or relating to diagnostic/therapeutic agents | |
AU3761495A (en) | Method for forming and packaging iontophoretic drug delivery patches and the like to increase stability and shelf-life | |
CA2271944A1 (en) | Formulation for electrically assisted delivery of lidocaine and epinephrine | |
HUP9900795A3 (en) | Sinergetical fungicide composition containing fenazaquine and amide compound as active ingredients and use thereof | |
AU1766595A (en) | Biologically active substance-secreting hybrid gel | |
AU2380595A (en) | Biologically active composition | |
AU6372496A (en) | Absorbent material, absorbent body made of the material, and method for the preparation of the material | |
AU696769B2 (en) | Mouth moistener for the relief of dry mouth condition | |
AU7277598A (en) | Energy delivery of catheter and method for the use thereof | |
EP1133979A3 (en) | Use of specific fatty compounds for modifying the physico-chemical properties of the skin and/or the mucous membrane as agents for preventing or reducing the adhesion of micro-organisms thereon | |
WO1998053850A3 (en) | Compositions and means for the treatment of burns and other cutaneous traumas | |
CA2348474A1 (en) | Pharmaceutically active composition and dispensing device | |
BG103262A (en) | Antimycotic gel with high degree of active substance release |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20130904 |